TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year book value per share growth

Latest
-55.94%
↓ 361% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
21.41%
Historical baseline
PeriodValue
2025-55.94%
2024-6.44%
2023-44.38%
2022-38.52%
2021494.96%
2020-199.81%
20190.00%